The American way...
If you can't build something that works, or cant't sell something that does work - sue.
As much as we would like to blame someone else, the FDA and Shorts are minor players in this fiasco.
Before bringing Afrezza to market:
MannKind should have had a trial to show superiority.
MannKind should have picked a partner that was committed to Afrezza.
MannKind should have worked out pricing, or at least had a plan to deal with insurance coverage. (Handing everything to Sanofi without demanding price parity was unworkable).
MannKind should have known how to titrate Afrezza properly. (They didn't even know when the best time to take Afrezza was)
MannKind should have addressed the required lung test before launching Afrezza.
MannKind should have more resources available to Patients (especially those issued samples).
etc. etc. etc.
After launch:
MannKind should have been proactive when dealing with Sanofi, the FDA, getting the Pediatric Trial done, etc.
The blame game can go on and on, but MannKind (Management) is responsible for where the stock price is, and for where scripts are.
----
FYI:
PWD = an abbreviated form of the word "password". That's from an IT guy... it probably has another dozen meanings. The first time you use something abbreviated/Acronyms (in a thread) it's a good idea to write it all the way out.
Except when you abbreviation's definition is made obvious by it's use in a sentence.
PWN = MannKind's investors have been 'pwned' by the Shorts.